Atrin Pharmaceuticals Overview

  • Founded
  • 2012

Founded
  • Status
  • Acquired/​Merged

  • Employees
  • 7

Employees
  • Latest Deal Type
  • M&A

Atrin Pharmaceuticals General Information

Description

Developer of anticancer therapeutic drugs designed to treat a broad spectrum of cancers associated with synthetic lethality and the deregulated DNA damage response. The company's drugs are hyperactive in cancer cells, perform a vital function without which the cancer cells could be destroyed, and create a molecule that causes the collapse of replication forks, enabling patients to get unusual, effective, and safe drugs for the treatment of cancer.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Parent Company
Primary Office
  • 3805 Old Easton Road
  • Doylestown, PA 18902
  • United States
+1 (267) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Atrin Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 16-May-2022 00.000 Completed Pre-Clinical Trials
6. Later Stage VC 01-Jul-2021 00.000 Completed Pre-Clinical Trials
5. Secondary Transaction - Private 00.000 Completed Startup
4. Later Stage VC 01-Oct-2019 00.000 00.000 Completed Startup
3. Later Stage VC 15-May-2017 000 000 Completed Startup
2. Grant 19-Oct-2016 $300K Completed Startup
1. Early Stage VC 22-Apr-2015 Completed Startup
To view Atrin Pharmaceuticals’s complete valuation and funding history, request access »

Atrin Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of anticancer therapeutic drugs designed to treat a broad spectrum of cancers associated with synthetic lethal
Drug Discovery
Doylestown, PA
7 As of 2022
00.000
000000&0 00.000

000000

is nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate veli
0000 000000000
South San Francisco, CA
00 As of 0000
00000
00000000 00000

000000

rem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et
0000 000000000
New York, NY
000 As of 0000
00000
000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Atrin Pharmaceuticals Competitors (5)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
IDEAYA Biosciences Formerly VC-backed South San Francisco, CA 00 00000 00000000 00000
00000000 000000000 Formerly VC-backed New York, NY 000 00000 000000000 00000
000000 00000000000 Formerly VC-backed Montreal, Canada 000 00000 00000000 00000
00000000000 Formerly PE-Backed Cambridge, United Kingdom 00000 000 00000000 000
000000 Corporation New York, NY 00000 000000000-00
You’re viewing 5 of 5 competitors. Get the full list »

Atrin Pharmaceuticals Patents

Atrin Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-10301324-B2 Ataxia telengiectasia and rad3-related (atr) inhibitors and methods of their use Active 12-Apr-2016 0000000000 0
US-20170291911-A1 Ataxia telengiectasia and rad3-related (atr) inhibitors and methods of their use Granted 12-Apr-2016 0000000000
US-20160102104-A1 Ataxia telengiectasia and rad3-related (atr) protein kinase inhibitors Granted 13-Oct-2014 0000000000
ES-2879441-T3 Protein kinase inhibitors related to ataxia telangiectasia and rad3 (atr) Active 13-Oct-2014 0000000000
JP-2017531041-A Telangiectasia ataxia and rad3-related (atr) protein kinase inhibitors Granted 13-Oct-2014 C07D498/08 0
To view Atrin Pharmaceuticals’s complete patent history, request access »

Atrin Pharmaceuticals Executive Team (7)

Name Title Board Seat Contact Info
Oren Gilad Ph.D Co-Founder, President, Chief Executive Officer, Principal and Board Member
Zachary Lynde Chief Financial Officer
Zeev Weiss Chief Business Officer
You’re viewing 3 of 7 executive team members. Get the full list »

Atrin Pharmaceuticals Board Members (9)

Name Representing Role Since
Jay Rosan Atrin Pharmaceuticals Board Member 000 0000
Jeffrey Dayno MD Self Board Member 000 0000
Marc Duey Self Board Member 000 0000
Michael Grissinger Self Board Member 000 0000
Oren Gilad Ph.D Atrin Pharmaceuticals Co-Founder, President, Chief Executive Officer, Principal and Board Member 000 0000
You’re viewing 5 of 9 board members. Get the full list »

Atrin Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Atrin Pharmaceuticals Former Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Aljit Joy Angel (individual) Minority 000 0000 000000 0
Ben Franklin Technology Partner of Southeastern Pennsylvania Venture Capital Minority 000 0000 000000 0
Bernard Rudnick Angel (individual) Minority 000 0000 000000 0
Duce Management Family Office Minority 000 0000 000000 0
Jason Bell Angel (individual) Minority 000 0000 000000 0
You’re viewing 5 of 10 investors. Get the full list »